GenDx's Amplification Primers for HLA Genes Receives CE Marking | GenomeWeb

NEW YORK (GenomeWeb) – GenDx today said that its NGSgo-AmpX for amplifying complete HLA genes for downstream sequencing has received CE marking.

The amplification primers can be used for Sanger sequencing and certain next-generation sequencing approaches and is the first CE-marked product for HLA typing for NGS, GenDx said. The product is platform-agnostic and suitable for the Illumina MiSeq, Ion Torrent PGM, and PacBio RS systems, among others.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of 200 bird species, and more.

The Australian High Court rules that isolated genetic material cannot be patented.

The startup incubator Y Combinator is launching a nonprofit research lab.

Wired's Sarah Zhang writes that the fight over who developed the CRISPR/Cas9 genome editing tool first underscores the history of parallel discoveries in science.

Sponsored by

This webinar will discuss the benefits of a rapid targeted next-generation sequencing (TNGS) panel, using dried blood spots, for second-tier newborn metabolic and hearing loss screening and its immediate utility for high-risk diagnostic testing in the neonatal intensive care unit. 

Sponsored by
Oracle Health Sciences

Brian Wells of Penn Medicine will detail how his team's "PennOmics" integrated healthcare data warehouse accelerates clinical trial recruitment at the point of care, accepts data from wearables, and does it all in a secure, HIPAA- and research-compliant fashion.